It took nearly a year for the current drugs to go from “under consideration” to be available on PBS.
I have a mate who did clinical trial for what is now known as Epclusa well over a year ago. He was cured.
Good to see more options becoming available, especially more effective and cross genotype ones.
M 61yo HCV+ ~ 30 yrs Gt1a F2 VL 223,000 ALT 54 AST 42 Tx start Sof/Dac 17Dec15.
SVR4 at 7Apr16 ALT 22 AST 22
SVR12 at 9Jun16 ALT 23 AST 25
Melbourne, Australia
.
